Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation.
Su, H., Zou, Y., Chen, G., Dou, H., Xie, H., Yuan, X., Zhang, X., Zhang, N., Li, M., Xu, Y.(2020) J Med Chem 63: 4090-4106
- PubMed: 32202425 
- DOI: 10.1021/acs.jmedchem.9b02107
- Primary Citation of Related Structures:  
6LJS, 6LJT, 6LJU, 6LJV, 6LJW, 6LJX - PubMed Abstract: 
Fatty-acid binding protein 4 (FABP4) is a promising therapeutic target for immunometabolic diseases, while its potential for systemic inflammatory response syndrome treatment has not been explored. Here, a series of 2-(phenylamino)benzoic acids as novel and potent FABP4 inhibitors are rationally designed based on an interesting fragment that adopts multiple binding poses within FABP4 ...